MedTrace Logo

Description of Individual Radiosensitivity With Molecular Biomarkers in a Pediatric Oncology Population

NCT02827552 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-02-12

No results posted yet for this study

Summary

This study aims to explore prospectively the distribution of individual radiosensitivity in the pediatric population and to determine the predictive power of individual radiosensitivity biomarkers from an immunofluorescence technique on primary dermal fibroblasts

Conditions

  • Cancer-related Problem/Condition

Interventions

OTHER

skin biopsy

skin biopsy performed prior radiation to characterize in blind the individual radiosensitivity of the patient

Sponsors & Collaborators

  • Institut de Cancérologie de Lorraine

    lead OTHER

Principal Investigators

  • VOGIN GUILLAUME, MD,PhD · Institut de Cancérologie de Lorraine

  • BERNIER CHASTAGNER VALERIE, MD · Institut de Cancérologie de Lorraine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-13
Primary Completion
2020-02-07
Completion
2020-02-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02827552 on ClinicalTrials.gov